These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Angiogenesis as determined by computerised image analysis and the risk of early relapse in women with invasive ductal breast carcinoma. Olewniczak S, Chosia M, Kołodziej B, Kwas A, Kram A, Domagała W. Pol J Pathol; 2003; 54(1):53-9. PubMed ID: 12817881 [Abstract] [Full Text] [Related]
12. The prognostic significance of multiple morphologic features and biologic markers in ductal carcinoma in situ of the breast: a study of a large cohort of patients treated with surgery alone. Cornfield DB, Palazzo JP, Schwartz GF, Goonewardene SA, Kovatich AJ, Chervoneva I, Hyslop T, Schwarting R. Cancer; 2004 Jun 01; 100(11):2317-27. PubMed ID: 15160334 [Abstract] [Full Text] [Related]
15. Expression of CD31 by cells of extensive ductal in situ and invasive carcinomas of the breast. Sapino A, Bongiovanni M, Cassoni P, Righi L, Arisio R, Deaglio S, Malavasi F. J Pathol; 2001 Jun 01; 194(2):254-61. PubMed ID: 11400156 [Abstract] [Full Text] [Related]
16. Angiogenin is up-regulated in the nucleus and cytoplasm in human primary breast carcinoma and is associated with markers of hypoxia but not survival. Campo L, Turley H, Han C, Pezzella F, Gatter KC, Harris AL, Fox SB. J Pathol; 2005 Apr 01; 205(5):585-91. PubMed ID: 15776477 [Abstract] [Full Text] [Related]
18. E-cadherin expression in invasive non-lobular carcinoma of the breast and its prognostic significance. Rakha EA, Abd El Rehim D, Pinder SE, Lewis SA, Ellis IO. Histopathology; 2005 Jun 01; 46(6):685-93. PubMed ID: 15910600 [Abstract] [Full Text] [Related]